Site Search
581 results for enter portal MAKEMUR.com How to get my case dismissed by paying the victim North Carolina
- Advisor Guide
-
New online course available
Boost your knowledge and earn CE Credits
Looking to deepen your understanding of Universal Life insurance and get a new CE Credit?
Equitable is excited to offer a new addition to our online learning center: The mechanics of Universal Life. Whether you are new to the concept or looking to refresh your expertise, this course will help provide the knowledge you need to start conversations with clients.
Our CE credit courses allow you to learn at your own pace and earn CE credits quickly and easily.
Available Courses:
• The mechanics of Universal Life *NEW*
• Introduction to Whole Life Insurance
• Participating Whole Life for the Children’s Market – A head start for tomorrow
• Path to Success - Expert Advice on Navigating CI Sales
• Ensuring a Compliant, Needs-based Insurance Sale
• Where UL Fits in your product portfolio
• Building your business with Critical Illness insurance
• Harness the Power of Whole Life Cash Value
A few important notes before you get started:
• The programs are hosted on Teachable: https://equitable-life-education.teachable.com
• Username: Please use your email address that you are contracted with
• Password: Equitable
• Please use Google Chrome to access the courses
You can earn CE credits right away when you complete these courses.
Start earning CE Credits!
Check out the individual insurance online learning centre on EquiNet to stay up to date on new courses.
All courses are accredited by Alberta Insurance Council, Insurance Council of Manitoba, The Institute for Advanced Financial Education, and Chambre de la sécurité financière*.
Questions?
Contact your local wholesaler.
Are you having trouble logging in?
Email equitableiimarketing@equitable.ca for assistance. - Marketing materials
- [pdf] Guide to MGA contracting
-
Earth Day: A simple way to talk about sustainable investing
Earth Day is a great time to talk with clients about investing with purpose. This year’s theme—Our Power, Our Planet—highlights the impact of individual and collective choices, including how we invest.
Many Canadians are interested in sustainable investing, which looks at environmental, social, and governance (ESG) factors alongside long term returns. Clients want to understand how the power of their money can support positive change—without sacrificing performance. Sustainable investing can look at things like reducing carbon impact, supporting fair workplaces, and encouraging strong company leadership.
Watch out for greenwashing
Not all investments labeled “sustainable” are the same. Some products may use the term without real environmental efforts or strategies. This is known as greenwashing.
That’s where advisors can add value. By understanding how funds are built and what they hold, you can help clients make informed choices they feel confident about.
How Equitable can help
Equitable® offers sustainable investing fund options that include ESG considerations as part of a disciplined investment approach. Take this opportunity to review available options and fund details.
You can also support sustainability through how you work with clients. Equitable’s paperless tools help reduce paper consumption and improve efficiency:
• Equitable Client Access® for online account viewing
• EZtransact® for fast, digital transactions
• EZcomplete® for easy, paper free applications
Take action
Earth Day is a great time to:
• Start simple conversations about sustainable investing
• Share Equitable’s sustainable fund options with clients
• Promote paperless tools that are better for clients and the environment
Small steps—done consistently—can make a meaningful difference for clients and the planet. If you have questions, speak with your Director, Investment Sales.
Date posted: April 22, 2026 - Advisor Guide
-
Policy endorsement: Contracts and group benefits plan booklet updates related to BC PharmaCare Biosi
As we announced in the June 2019 issue of eNews, BC PharmaCare recently introduced a new Biosimilars Initiative that ends coverage of three biologic drugs, including Remicade, Enbrel, and Lantus. These drugs will no longer be eligible in British Columbia for most conditions for which lower-cost biosimilar versions are available. Patients in the province with these conditions will be required to switch to biosimilar versions of these drugs by Nov. 25, 2019 in order to maintain their coverage under BC PharmaCare.
The following table outlines the affected originator drugs and their biosimilars.
Drug Originator Biosimilar etanercept Enbrel® Brenzys®
Erelzi™infliximab Remicade® Inflectra®
Renflexis®insulin glargine Lantus® Basaglar™
Biologics are drugs that are engineered using living organisms, such as yeast and bacteria. Biosimilars are highly similar to the originator drugs they are based on and most have been shown to have no clinically meaningful differences in safety or efficacy.
To ensure this provincial change doesn’t result in your clients' plans paying additional drug costs, we are aligning our drug eligibility for these three biologic drugs with that of BC PharmaCare.
To facilitate this change, we are amending some of the wording in our contracts and booklets, effective Oct. 1, 2019. Below are links to the Endorsement to the Master Policy and the Summary of Master Booklet Wording Changes for those amendments. Please download and save these policy endorsement documents for your files.
In addition, please remind your clients to provide their plan members with a copy of the Summary of Master Booklet Wording Changes. The next time your clients amend their benefits plans, the updated wording will be included in their group benefits plan bookletsDOWNLOAD ENDORSEMENT TO THE MASTER POLICY
DOWNLOAD SUMMARY OF MASTER BOOKLET WORDING CHANGES
As of Nov. 25, 2019, Remicade and Enbrel will no longer be eligible for BC plan members with conditions for which lower-cost biosimilar versions of the drugs are available. These plan members will be required to switch to the biosimilar versions of these drugs in order to maintain eligibility on the Equitable Life drug plan.
We will be communicating with affected claimants in the coming weeks to allow them ample time to change their prescription and avoid any interruptions in their treatment or their coverage.
We intend to take a similar approach to Lantus. However, we are still investigating the options to implement this change. We will be communicating with you in the coming weeks to confirm our approach for this drug.
If you have any questions about this change, please contact your Group Marketing Manager or myFlex Sales Manager.
® and ™ denote trademarks of their respective owners - Dividend Withdrawals and Change and Premium Offset
- Policy Loan
- Banking Changes